Viewing Study NCT07281456


Ignite Creation Date: 2025-12-24 @ 11:15 PM
Ignite Modification Date: 2025-12-25 @ 8:52 PM
Study NCT ID: NCT07281456
Status: RECRUITING
Last Update Posted: 2025-12-23
First Post: 2025-12-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module